ICPR 2024
Europe's leading conference on psychedelic science and therapy
June 6, 2024 - June 8, 2024
Philharmonie, Haarlem, The Netherlands
Interdisciplinary Conference on Psychedelic Research
0+
Speakers
0+
Sessions
Santiago Alonso González
Translator & Bridge between the Wixárika Nation and the Modern World
Rogelio Carillo
Wixárika (Huichol) Community of San Andrés Cohamitra
Terence ChingPhD
Department of Psychiatry, Yale School of Medicine
Clayton ColemanMSc
Psychedelics Researcher
King's College London
Jonathan David
PhD Candidate and Psychologist
University of Haifa Mount Carmel
Maya Gal-birmanMSc
Therapist & Psychedelics Researcher
Bar Ilan University
Caroline HayesMBBS
Core Psychiatry Trainee
Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
Katelijne Van Der HeijdenMD
Leiden University Medical Centre & Centre for Human Drug Research
Andreas KrabbeMSc
PhD Candidate & Clinical Neuroscientist
Åbo Akademi University
Mauricio Lobao
Mendel
Founder and CEO at Wavepaths, United Kingdom
Torsten PassieMD, PhD
Professor of Psychiatry & Psychotherapy
Hannover Medical School; Gotha-University Frankfurt/Main
Radio Patapoe
dj Rump3lst!lstsk!
Marijn van Iwaarden
Isa Wagenaar
Day 1 (55)
Registration
registration
ICPR 2024 Official Opening
ceremony
Room Change
break
Doors of perception
talk
The paleolithic psychedelic experience: caves as doors of perception
09:50 AM - 10:20 AM • Griffiths GalleryIntegrating integration
talk
Connecting to plant teachers in times of chaos
09:50 AM - 10:20 AM • Sabina StagePharmacology of psychedelics
talk
Clinical pharmacology of psychedelics and MDMA
09:50 AM - 10:20 AM • Osmond AuditoriumRoom Change
break
Ethical perspectives and best practices
session
Ethical issues with psychedelic-assisted treatments in psychiatry: a systematic scoping review
talk
Integrating integration
session
Navigating the psychedelic integration landscape: adapting practices in response to expanding horizons
talk
Psychedelics and the immune system
session
Characterization of microglial functional and phenotypic modulation upon psychedelic treatment using human in vitro cellular models
talk
Best practices for patient-centred psychedelic clinical trials
talk
Interactive Q&A session
talk
Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: an experimental, placebo-controlled study
talk
Should science and technology studies make psychedelic research more responsible?
talk
Break
break
Broader perspectives on psychedelics
session
Reflections on three decades of change and challenge
talk
Bridging the psychedelic explanatory 'gap'
symposium
The role of setting
session
The Delphi study on setting
talk
The mindful use of psychiatric medication: a report from the psychoactive clinic project and a proposed model for psychiatric care
talk
The dynamics of psychedelic diffusion
talk
Psychedelic wonder and awe in socio-cultural context
talk
Lunch & Poster Presentations
break
Psychedelics and drug policy reform
talk
Integrating the psychedelic renaissance and broader drug policy reform
02:20 PM - 03:00 PM • Griffiths GalleryPsychedelics for OCD
session
Drug-drug interactions
session
Safety first: evaluating toxicology and pharmacological interactions with psychedelics and psychiatric medications
talk
SPL026 (DMT fumarate) in combination with SSRIs for patients with major depressive disorder
talk
Room Change
break
Psychedelics, spirituality, community, tradition & religion
panel
Inside perspectives on MDMA-assisted therapy
panel
Journey of a lifetime. Patient and therapist perspectives on MDMA-assisted therapy for PTSD
03:10 PM - 03:50 PM • Sabina StageHistorical perspectives
session
Historical representations around peyote during the early XX century in Mexico
talk
Shamanic journeys in the East: deciphering the psychedelic wisdom of ancient Iranian magi
talk
Break
break
Consciousness, psychedelics, insights
session
Consciousness, self, and psychedelic insights
talk
Informed consent: suggestibility, efficacy, and morality
panel
(De)colonization of psychedelics
panel
Bewusstseinskultur, intellectual honesty, and insight
talk
Room Change
break
How can psychedelics inform the science of consciousness?
panel
Live Performance
performance
Navigating the high seas: confronting the challenges of the psychedelic renaissance
panel
Relax and Connect
networking
Neurophenomenology of DMT and 5-MeO-DMT
talk
The handiest of the marks: the neurobiology of language partially mediates the psychedelic experience
talk
Insights from a field study on the effects of 5-MeO-DMT administered via vaporization vs intramuscular injection
talk
Mapping the 5-MeO-DMT experience: insights from microphenomenology interviews in phase 1 trials
talk
Effects of single-dose psilocybin with non-directive support in the treatment of obsessive-compulsive disorder
talk
Effects of single-dose psilocybin with non-directive support in the treatment of obsessive-compulsive disorder: A case series analysis of non-responders in a randomized, double-blind, placebo-controlled trial
talk
Day 2 (66)
Arrival
arrival
Psychedelic plants and animals
session
Kinship with psychedelics: plants and fungi in the therapeutic relationship
talk
Critical perspectives
session
Who benefits from the psychedelic 'Renaissance'? Indigenous reciprocity, decolonization, and plant medicine conservation
talk
Extended DMT
session
Safety, pharmacokinetics and pharmacodynamics of N,N-dimethyltryptamine (DMT) administered intravenously over 6 hours to healthy volunteers
talk
Acute effects of extended DMT
talk
The psychedelic animal
talk
Is mainstreaming psychedelics a good thing?
talk
Phenomenology of extended state DMT
talk
Room Change
break
Psychedelics and death
session
Psilocybin-assisted therapy for cancer patients, a real-world case series
talk
The Kamentsá perspective on Yagé
talk
Healing, ancestral legacy of our elders
10:30 AM - 11:20 AM • Sabina StagePsychedelic humanities
session
On psychedelic humanities: interdisciplinary challenges to an emerging field
talk
Ayahuasca-assisted psychotherapy for prevention of persistent complex bereavement disorder
talk
Psychedelic feminism: learning from transcendental processing in women's bodies
talk
Break
break
Therapist training
session
Should controlled self-experience with psychedelic drugs be part of the training of psychedelic therapists
talk
Spirituality in psychedelic research and therapy
symposium
Exploring the intersection of psychedelics and attachment theory
symposium
Advancements and challenges in psychedelic-assisted psychotherapy: insights from Swiss practice and therapist training
talk
Lunch & Poster Presentations
break
Therapist training
panel
Psychedelics and spirituality
session
The DMT experience
session
What the world is seeing on DMT: quantifying and measuring visual experiences of DMT
talk
Language, magic, and alien Intelligence: esotericism and mystery in Terence McKenna's description of the DMT experience
talk
Room Change
break
Advancing psychedelic treatments at the end of life
panel
Psychedelics in times of war
session
Providing psychedelic-informed therapy for the survivors of October 7th
talk
Drug development and novel psychedelic compounds
session
First-in-human studies with novel psychedelic compounds: pharmacological characterization based on the question-based drug development (QBDD) approach
talk
The potential economic and public health impact of MDMA-AT for PTSD in Ukraine
talk
Acute effects of individual R- and S-MDMA enantiomer administration compared with racemic (+)-MDMA in a randomized double-blind cross-over trial in healthy participants
talk
Break
break
How to bring MDMA to patients
session
The Dutch State committee on MDMA: report presentation
talk
Technodelia and ecodelics
symposium
Mental health professionals' views and experiences
symposium
The psychedelic renaissance: finding the balance between public benefit and returns to shareholders
talk
Room Change
break
Psychedelic medicalisation: What can a square peg teach a round hole?
panel
Film Screening
film
Colectivo los ingrávidos
05:30 PM - 06:15 PM • Sabina StagePsychedelic-assisted therapies for couples and relationships
panel
Relax and Connect
networking
Spiritual expertise in psychedelic research
talk
How to evaluate the rationality or delusionality of psychedelically induced changes in metaphysical beliefs and worldviews?
talk
Are mystical-type experiences key to the therapeutic effects of psychedelics? State of the research and evidence
talk
Beyond the visible: Ayahuasca's transformative influence on attachment security through entity encounters
talk
Attachment alchemy: Exploring the role of attachment and emotional regulation in psilocybin retreat experiences
talk
Relevance of perceived attachment history and attachment in adulthood to naturalistic psychedelic experiences
talk
The necessity of regulating psychedelic spiritual care
talk
Psychedelic chaplaincy
talk
Enchanted by "Blue flowers of technology": mimetic excess in ecodelic cinema
talk
Al Pharmakon: artificial intelligence as techgnostic conduit of ecodelic consciousness
talk
One for all and the trans history of ketamine
talk
Between psychedelics and aesthetics: cinema-trance as relational healing practice
talk
American psychiatrists' changing views on psychedelics and their potential therapeutic applications
talk
Psychedelic use among psychiatrists and psychiatric medication prescribers: effects on well-being, depression, anxiety, and stigmatizing attitudes
talk
Personal psychedelic use is common among a sample of psychedelic therapists: implications for research and practice
talk
Psilocybin-assisted therapist training: outcomes from a world-first study
talk
Day 3 (58)
Arrival
arrival
MDMA-assisted therapy
session
Preliminary results from the pilot trial of cognitive processing therapy + MDMA for PTSD
talk
How to deal with the unavailability of legal psychedelic therapies in Europe
panel
Field research
session
The nuts and bolts of field-studies: lessons learned in collaboration with psychedelic retreats
talk
MDMA-Assisted therapy as a treatment for anxiety secondary to terminal illness, a qualitative follow-up analysis
talk
EEG hyperscanning during an ayahuasca ceremony in the Amazon - a pilot study
talk
Room Change
break
Psychedelic treatment for anxiety
session
Psilocybin-assisted psychotherapy for generalised anxiety disorder: safety and efficacy in a world-first randomised controlled trial
talk
Interrogating integration
panel
Measuring the effects of psychedelics
session
Measuring recalled psychedelic experience: experiment results and invitation to a many-analysts project on subjective effects
talk
Psilocybin-assisted psychotherapy for generalised anxiety disorder: examining the role of expectations, masking rates, and 'placebo' responding in a world-first randomised controlled trial
talk
The Swiss Psychedelic Side Effects Inventory: systematic assessment of adverse effects from psychedelics and MDMA?
talk
Break
break
Transdiagnostic therapeutic mechanisms
session
Reopening critical periods with psychedelics: basic mechanisms and therapeutic opportunities
talk
DMT science in Brazil
symposium
Queering psychedelics
symposium
Claustrum and cognitive control as potential transdiagnostic therapeutic targets of psychedelic drugs
talk
Lunch & Poster Presentations
break
Difficult experiences
session
Contraindications for psychedelic therapy: a case report
talk
Pathways to access in Europe
panel
LSD for depression and anxiety
session
LSD for depression: a randomized, double-blind, low dose-controlled phase II trial
talk
Extended difficulties after psychedelics and what helps people cope with them
talk
LSD-assisted therapy in patients with anxiety: a prospective 12-month follow-up
talk
Room Change
break
The psychedelic underground
talk
Between God and crime: the legacy of the underground
03:10 PM - 03:50 PM • Griffiths GalleryPatient and therapist perspectives on psilocybin therapy for depression
talk
"Oh boy, did I respond!" - Participant and clinician reflections on a challenging experience in a clinical trial with psilocybin for depression
03:10 PM - 03:50 PM • Sabina StageThe role of (social) connection
session
Connection is not enough: or, welcome to the Mushroomocene
talk
Putting the social cure (back) into psychedelic treatments: a research agenda for harnessing social identity and social connection to improve therapeutic success
talk
Break
break
Psychedelics for depression
symposium
Indigenous perspectives
panel
Literary analysis
session
Psychedelic Dolce Vita. How LSD impacted on Fellini's creativity. A phenomenological study
talk
Dr Hoffmann, the determination police, and Angela Carter's critique of the counterculture
talk
Storytelling: Lighting the latern leaf: promoting therapeutic psychedelics via eco-science fantasy
talk
Plenary Closing Panel
ceremony
Relax & Connect
networking
The antidepressant effects of ayahuasca: a randomized controlled trial
talk
The antidepressant effects of vaporized DMT: a phase lla trial
talk
Safety and tolerability of vaporized DMT: a phase I trial
talk
Beyond symptoms and behaviors: exploring N-N-DMT modulation on molecular biomarkers of depression
talk
From insights to action: queer, diverse, and culturally attuned psychedelic research
talk
Sexuality and psychedelics: from counterculture to modern science
talk
Queering couples therapy with MDMA
talk
Reclaiming ecstasy: the transformative power of pleasure in queer psychedelic healing
talk
Embracing Identity: Psychedelics and the GLBT+ Community
talk
Psilocybin for treatment-resistant major depression - First results and learnings from the EPISODE trial
talk
Psilocybin-assisted therapy increases emotional empathy in patients with major depression
talk
Avoidance and acceptance in psilocybin-augmented psychotherapy for depression
talk
The (new) great psychotherapy debate: the role of adjunctive therapy in psychedelic interventions and implications for long-term outcomes
talk